Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification [NA]
This clinical trial update outlines an approach to treating early type 2 diabetes by reducing postprandial glucose excursions through lifest…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes [NA]
A clinical trial is evaluating the efficacy heterogeneity of the probiotic Lactobacillus paracasei LC19 for Type 2 diabetes mellitus. The st…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia [NA]
A Mayo Clinic study aiming to improve diabetes management for adults experiencing severe hypoglycemia is currently suspended. No results are…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update for NT-0796 examining its efficacy and safety in obesity with or without type 2 diabetes mellitus; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy [Phase 2]
A Phase 2 clinical trial evaluating icovamenib in adults with type 2 diabetes mellitus who are not reaching glycemic targets on GLP-1-based …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil [Phase 1]
A Phase 1 bridging study of Efsubaglutide Alfa in healthy adults in Brazil is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both [Phase 3]
A Phase 3 trial comparing CagriSema to Tirzepatide in adults with Type 2 diabetes treated with metformin and/or SGLT2 inhibitors to evaluate…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) [NA]
This clinical trial update describes the IRIS-CKD program (Implementation program to Improve Screening and Management for CKD in Diabetes, P…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets [Phase 2]
A Phase 2 clinical trial update for icovamenib in adults with type 2 diabetes who are not achieving glycemic targets; the study status is re…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy [NA]
A clinical trial evaluating dietary strategies and nutritional education for adults with obesity and/or type 2 diabetes who are on GLP-1 the…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes [NA]
A clinical trial is currently recruiting to assess whether fecal microbiota transplantation can alter gut microbiota composition and improve…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial update describing a study to evaluate the safety and efficacy of iGlarLixi in adults with Type 2 diabetes mellitus;…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) [NA]
This entry describes the IRIS-CKD program (Program 2) sponsored by Duke University, an implementation study to improve screening and managem…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery [Phase 2]
Phase 2 clinical trial evaluating the effect of dapagliflozin on glucose variability in patients after bariatric surgery.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) [Phase 3]
VK2735 is being studied in a Phase 3 trial (VANQUISH 2) for weight management in adults with type 2 diabetes, and the trial is currently act…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
This UC Davis-sponsored clinical trial is recruiting to evaluate pregnancy and postpartum breastfeeding support for patients with gestationa…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating how weekly insulin icodec compares with daily basal insulins in adults with Type 2 diabetes is currently…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH [Phase 4]
A Phase 4 clinical trial at Massachusetts General Hospital is studying genetic links related to exposure to oral semaglutide, with participa…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes [Phase 3]
Phase 3 study evaluating a triple-combination regimen of Prusogliptin, Dapagliflozin, and extended-release Metformin for type 2 diabetes; th…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan [EARLY_Phase 1]
This early-phase trial plan explores the cardiovascular benefits of SGLT2 inhibitors and ketone strategies in people with type 2 diabetes an…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Autologous Islet Transplantation for Diabetes [EARLY_Phase 1]
An early-phase trial (Phase 1) is enrolling by invitation for autologous islet transplantation as a treatment for Type 2 diabetes at Shangha…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets [Phase 1]
Phase 1 clinical trial update evaluating the effects of food on pharmacokinetics and the safety of multi-dose chiglitazar/metformin extended…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals [NA]
This clinical trial assesses whether whey protein ingestion improves glucose control in people with prediabetes or type 2 diabetes, and is c…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study [NA]
This clinical trial assesses the effects of vasopressors ephedrine, phenylephrine, and norepinephrine on myometrial contractility in pregnan…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
A clinical trial is recruiting to assess pancreatic dysfunction in patients with Type 2 diabetes, investigating pancreatogenic diabetes mell…